Hay I D, Bergstralh E J, Goellner J R, Ebersold J R, Grant C S
Division of Endocrinology and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
Surgery. 1993 Dec;114(6):1050-7; discussion 1057-8.
Multivariate analyses in papillary thyroid carcinoma (PTC) have shown that age, tumor size, local invasion and distant metastasis are independent predictive variables. This study attempted to define a reliable prognostic scoring system for predicting PTC mortality rates with 15 candidate variables that included completeness of primary tumor resection but excluded histologic grade and DNA ploidy.
The study group comprised 1779 patients with PTC (followed up for > 26,000 patient-years), divided by treatment dates into 1940 to 1964 (n = 764) and 1965 to 1989 (n = 1015). Cox model analysis and stepwise variable selection led to a prognostic model initially derived from the training set (n = 764). The initial prognostic score was thereafter validated externally with the later (1965 to 1989) "test" data set.
The final model included five variables abbreviated by metastasis, age, completeness of resection, invasion, and size (MACIS). The final prognostic score was defined as MACIS = 3.1 (if aged < or = 39 years) or 0.08 x age (if aged > or = 40 years), + 0.3 x tumor size (in centimeters), +1 (if incompletely resected), +1 (if locally invasive), +3 (if distant metastases present). Twenty-year cause-specific survival rates for patients with MACIS less than 6, 6 to 6.99, 7 to 7.99, and 8+ were 99%, 89%, 56%, and 24%, respectively (p < 0.0001).
Because the five variables needed for MACIS scoring are readily available after primary operation, such a prognostic system could have widespread applicability in assessment of PTC.
甲状腺乳头状癌(PTC)的多变量分析表明,年龄、肿瘤大小、局部侵犯和远处转移是独立的预测变量。本研究试图用15个候选变量定义一个可靠的预后评分系统,以预测PTC死亡率,这些变量包括原发肿瘤切除的完整性,但不包括组织学分级和DNA倍体。
研究组由1779例PTC患者组成(随访超过26000患者年),按治疗日期分为1940年至1964年组(n = 764)和1965年至1989年组(n = 1015)。Cox模型分析和逐步变量选择得出一个最初源自训练集(n = 764)的预后模型。此后,最初的预后评分用后来(1965年至1989年)的“测试”数据集进行外部验证。
最终模型包括五个变量,缩写为转移、年龄、切除完整性、侵犯和大小(MACIS)。最终预后评分定义为:若年龄≤39岁,MACIS = 3.1;若年龄≥40岁,MACIS = 0.08×年龄,+ 0.3×肿瘤大小(厘米),+1(若切除不完全),+1(若有局部侵犯),+3(若有远处转移)。MACIS小于6、6至6.99、7至7.99和8及以上的患者20年特定病因生存率分别为99%、89%、56%和24%(p < 0.0001)。
由于MACIS评分所需的五个变量在初次手术后即可轻易获得,这样的预后系统在PTC评估中可能具有广泛的适用性。